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Dosage compensation in mammals involves silencing of one X chromosome in XX females and requires expression, in
cis,o fXist RNA. The X to be inactivated is randomly chosen in cells of the inner cell mass (ICM) at the blastocyst stage of
development. Embryonic stem (ES) cells derived from the ICM of female mice have two active X chromosomes, one of
which is inactivated as the cells differentiate in culture, providing a powerful model system to study the dynamics of X
inactivation. Using microarrays to assay expression of X-linked genes in undifferentiated female and male mouse ES
cells, we detect global up-regulation of expression (1.4- to 1.6-fold) from the active X chromosomes, relative to
autosomes. We show a similar up-regulation in ICM from male blastocysts grown in culture. In male ES cells, up-
regulation reaches 2-fold after 2–3 weeks of differentiation, thereby balancing expression between the single X and
the diploid autosomes. We show that silencing of X-linked genes in female ES cells occurs on a gene-by-gene basis
throughout differentiation, with some genes inactivating early, others late, and some escaping altogether.
Surprisingly, by allele-specific analysis in hybrid ES cells, we also identified a subgroup of genes that are silenced in
undifferentiated cells. We propose that X-linked genes are silenced in female ES cells by spreading of Xist RNA through
the X chromosome territory as the cells differentiate, with silencing times for individual genes dependent on their
proximity to the Xist locus.
Citation: Lin H, Gupta V, VerMilyea MD, Falciani F, Lee JT, et al. (2007) Dosage compensation in the mouse balances up-regulation and silencing of X-linked genes. PLoS Biol
5(12): e326. doi:10.1371/journal.pbio.0050326
Introduction
In many higher eukaryotes, sex determination mechanisms
have evolved in a way that has generated chromosomal
differences between the sexes. In eutherian and marsupial
mammals and the fruit ﬂy Drosophila, females have two copies
of a gene-rich X chromosome, whereas males have one X and
one smaller, gene-poor Y. Because monosomy for even the
smallest autosome is lethal in mammals, mechanisms have
presumably evolved to allow males to tolerate monosomy of
the X, as well as to correct a potential imbalance between the
sexes in expression levels of several hundred X-linked genes
[1,2]. In Drosophila, the situation has been resolved by an
overall up-regulation of genes on the single male X, a dosage
compensation mechanism that equalises expression both
between X and autosomes and between the sexes [3,4]. In
mammals, expression in males and females has been balanced
by X inactivation, a process by which most genes on one of
the two female Xs are silenced early in development [5–7].
However, X inactivation alone exacerbates the X:autosome
imbalance, leaving both sexes functionally monosomic for X-
linked genes. This problem was highlighted many years ago,
and a balancing, 2-fold up-regulation of genes from the
single, active X was proposed as a possible solution [2,8].
However, proof of this has been difﬁcult to achieve. Studies of
the expression of the Ccl4 gene in hybrid mice provided a clue
that this might occur [9], but the ﬁrst indication that genes on
the active X are globally up-regulated has come only recently
through the analyses of microarray data from a variety of
publicly available sources. Comparisons of the mean, overall
expression levels of X-linked and autosomal genes in various
cell and tissue types, usually from mixtures of male and
female, gives an X:autosome expression ratio of approxi-
mately 1 [10–12]. Given that both XY male and XX female
cells have only a single, transcriptionally active X, and two
copies of each autosome, without up-regulation of X-linked
genes the mean ratio should be closer to 0.5. The results
therefore provide evidence, albeit circumstantial, for a
balancing up-regulation of expression from the active X.
We used microarray expression analysis to give a global
picture of X-linked gene expression in differentiating mouse
embryonic stem (ES) cells, a model system that allows the
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[13]. We show that up-regulation of X-linked genes is in place
in undifferentiated male and female ES cells but is incom-
plete, with equalization of X-linked and autosomal transcript
levels requiring 2–3 wk of differentiation. Evidence for a
similar up-regulation was found in inner cell mass (ICM) cells
isolated from male and female blastocysts. In female ES cells,
continuing up-regulation through differentiation is counter-
balanced by silencing of genes on the second, randomly
chosen X. We show that silencing of X-linked genes occurs on
a gene-by-gene basis throughout differentiation, and we
present evidence that silencing is mediated by the progressive
spreading of Xist RNA through the X chromosome territory.
Results
Expression of X-Linked Genes Is Up-Regulated in Both
Female and Male ES Cells
Expression of X-linked genes in female and male ES cells,
relative to autosomal genes (X:A ratio), was assayed by co-
hybridisation of labelled cDNAs to NIA15K mouse cDNA
microarrays [14]. Expression levels of 180 X-linked genes (see
Text S1 for ﬁltering criteria) were distributed over a ;200-
fold range, with a close correlation between expression in
female and male cells (Figure 1A and 1B). Only two genes
showed clear sex-speciﬁc expression in undifferentiated ES
cells, namely Xlr3b and Xlr5, both of which showed minimal
expression in the CCE/R male line. Consistent over-expres-
sion of Xlr5c and Xlr5d in female ES cells relative to males has
recently been reported by others [15]. On differentiation, the
expression of both these genes increased progressively in
male CCE/R cells and decreased in female PGK12.1 cells, such
that by day 21, expression was at comparable levels in both
cell types (Figure S1A). Interestingly, Xlr3b and Xlr5 are part
of a cluster, some of whose members show tissue-speciﬁc
imprinting [16]. For undifferentiated cells (Figure 1A), the
regression line intercepts the y-axis (female) at a positive
value (log2¼0.69, linear 1.61), showing that overall expression
of X-linked genes is 1.6-fold higher in undifferentiated female
ES cells, with two active X chromosomes, than in male ES
cells, with only one. In differentiated cells (Figure 1B), the
intercept was close to 0 (log2 ¼ 0.14, linear 1.10), indicating
that overall expression of X-linked genes was very similar in
differentiated male and female cells.
The distributions of expression levels of X-linked genes in
male and female ES cells are shown as box plots in Figure 1C.
In both males and females, expression levels are skewed
towards higher expression levels (Figure S2). A similar
skewing was seen when the expression of genes on individual
autosomes was analysed in the same way (Figure S2). To
accommodate this, we have used median rather than mean
values for comparison (Figure 1C, horizontal line in each
box). The median X:A ratio in undifferentiated (day 0) male
ES cells is 0.81 (Figure 1C). This is signiﬁcantly above the
median value of 0.5 that would be expected if X-linked genes
were expressed equally to autosomal genes (p ¼ 3.2 3 10
 32, n
¼ 249) and demonstrates an overall 1.6-fold up-regulation of
expression on the single X. Microarray expression data for
three additional male ES cell lines has recently been made
available (BL6.9, 129.3, and ES-D3-GL) [15], and we have used
this to calculate X:A expression ratios, as above. Values
ranged from 0.90 to 1.03, suggesting that an approximately 2-
fold up-regulation of X-linked genes is a general property of
male ES cell lines.
In XX female cells, equal expression of X-linked and
autosomal genes would give an X:A ratio of about 1.0,
whereas the measured ratio is 1.39, which is signiﬁcantly
higher (Figure 1C, p ¼1.1310
 6, n¼249). A very similar X:A
expression ratio (1.37) was given by cDNA from the hybrid,
female ES cell line 3F1 (see below). Thus, X-linked genes in
female ES cells are also up-regulated. After 15 d of differ-
entiation, X:A ratios in both male and female cells were close
to 1, which is comparable to the situation in adult cells
(Figure 1C).
Expression of X-Linked Genes in the ICM
To test whether the up-regulation of X-linked genes
detected in ES cells also occurs in the cells of the blastocyst
from which ES cells are derived, RNA was prepared from
single ICMs from cultured male and female embryos
(distinguished by presence or absence of the Sry gene, Figure
2A), ampliﬁed and used to prepare cDNA for labelling of
NIA15K arrays. As with expression in ES cells, the expression
of X-linked genes in female and male embryos was closely
correlated (Figure 2B). The median X:A ratio in male ICMs
was 0.86 (Figure 2C), very similar to the value of 0.81 obtained
for male ES cells (Figure 1C) and indicative of up-regulation
of X-linked gene expression. In female ICMs from the same
batch of embryos, the X:A ratio was 0.89 (Figure 2C). This is
consistent with up-regulation of genes on Xa in females only
if one of the two Xs is inactivated in all or most of the ICM
cells used in this experiment. This is certainly possible,
because levels of Xist RNA were particularly high in female
ICMs (around 8-fold higher than the median expression of
autosomal genes) and signiﬁcantly higher than the Xist RNA
levels in male ICM (Figure 2D) and differentiated female ES
cells (Figure 1B). Whether this represents persistence of the
imprinted paternal X inactivation present from early in
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Author Summary
In organisms such as fruit flies and humans, major chromosomal
differences exist between the sexes: females have two large, gene-
rich X chromosomes, and males have one X and one small, gene-
poor Y. Various strategies have evolved to balance X-linked gene
expression between the single X and the autosomes, and between
the sexes (a phenomenon called dosage compensation). In
Drosophila melanogaster, expression from the male X is up-regulated
approximately 2-fold, thereby balancing both X-to-autosome and
female-to-male expression. In contrast, mammals silence one of the
two female Xs in a process requiring the untranslated RNA product
of the Xist gene. This balances female-to-male expression but leaves
both sexes with only one functional X chromosome. Using mouse
embryonic stem cells and microarray expression analysis, we found
that dosage compensation in mice is more complex than previously
thought, with X-linked genes up-regulated in both male and female
cells so as to balance X-to-autosome expression. As differentiation
proceeds, female cells show progressive loss of expression from one
of the two initially active Xs. Surprisingly, silencing occurs on a gene-
by-gene basis over 2–3 week of differentiation; some genes escape
altogether, whereas a subgroup of genes, often adjacent to the Xist
locus, is silenced even in undifferentiated cells. We propose that
female X-linked genes are silenced by progressive spreading of Xist
RNA through the X chromosome territory as differentiation
proceeds.development, or random X inactivation, or a combination of
the two [17], remains to be determined.
Changes in Expression of X-Linked Genes Proceed
throughout ES Cell Differentiation
The dynamics of differentiation-related changes in X-
linked gene expression were determined by analysing cDNAs
from male and female cells at various times of differentiation
between 0 and 21 d. The X:A expression ratio in female cells
showed a gradual and progressive decrease until day 15,
whereas in male cells, there was little change until day 7, after
which there was a progressive increase (Figure 3A). The
gradual changes in X-linked gene expression contrast with
the relatively early change in distribution of Xist silencing
RNA detected by RNA–ﬂuorescence in situ hybridisation
(FISH) (Figure 3B) and loss of expression of the pluripotency
markers Nanog, Pou5f1/Oct4, and Zfp42/Rex1 (Figure S1B). Xist
RNA levels increased through differentiation from day 2
onwards (Figure S1C).
The observed increase in expression of X-linked genes in
differentiating male cells and the decrease in female cells are
unique properties of X-linked genes. Expression of genes on
each of the 19 mouse autosomes, relative to all genes
(designated the n:A ratio) showed no such changes. The n:A
ratio varied from one chromosome to another over only a
narrow range and did not change with differentiation or
differ between females and males to the same extent as did
the X:A expression ratio (Chromosome 2 is shown as an
example in Figure 3C and all 19 autosomes are shown in
Figure S3).
The expression of X-linked genes in differentiating female
ES cells can potentially be inﬂuenced by the following three
parallel processes: (i) silencing through X inactivation, (ii) up-
regulation through dosage compensation on the active X, and
(iii) differentiation-related expression changes that are
unconnected to the dosage compensation process. Given
the close correlation between expression levels of X-linked
genes in male and female cells throughout differentiation
(Figure 1A and 1 B), the latter two processes are likely to
occur to a similar extent in both male and female cells. This
being the case, changes in the female:male expression ratio of
X-linked genes should reﬂect progression of the X inactiva-
Figure 1. Expression of X-Linked Genes Is Consistently Higher in Female than in Male ES Cells Prior to Differentiation
(A and B) Correlation in expression levels of X-linked genes between female (y-axis) and male (x-axis) ES cells. The value for each of the 249 clones (180
genes) shown is expressed relative to the expression of autosomal genes (X:A ratio, log2 scale). Two genes, Xlr3b and Xlr5, showed female-specific
expression prior to differentiation (panel A). Xist is weakly expressed overall, but relatively more strongly expressed in differentiated female ES cells than
in males (panel B). Pearson product moment correlation coefficients (r values) are shown, along with estimates of the probability of chance correlation
(p) corrected for false discovery rate (FDR).
(C) Box plots (linear scale) showing the distribution of expression of X-linked genes in female and male ES cells before (day 0) and after (day 15)
differentiation and in lymphocytes. The box encompasses the 25th–75th percentile and the upper and lower lines represent the 10th–90th percentile.
Outlying values are shown as individual dots. Data are from at least two biological replicates.
doi:10.1371/journal.pbio.0050326.g001
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Dosage Compensation in Embryonic Stem Cellstion process alone. With this in mind, we co-hybridised red/
green labelled cDNAs from female and male cells, at the same
stage of differentiation, to the same slide, and we calculated
red:green or green:red ratios as a log2 ‘‘M value’’, as described
[18,19]. In undifferentiated, cells the M value is around 0.65
(Figure 4A), corresponding to a linear female:male expression
ratio of about 1.6. M values derived from undifferentiated
cells and cells at later stages of differentiation were all
normally distributed (Figure 4B). There was no detectable fall
in M value for the ﬁrst 7 d of differentiation, with a small
increase at days 2–4. Thereafter, there was a progressive
decrease, culminating in an M value close to 0, which reﬂects
equal expression of X-linked genes in female and male cells
by day 21 (Figure 4A and 4B). It seems that a net loss of
expression of female X-linked genes occurs later than
previously concluded on the basis of single-gene analyses
[13,20].
To determine the consistency of these ﬁndings between ES
cell lines, we assayed X-linked gene expression in the hybrid
(m. mus domesticus3m. mus castaneous) ES cell line 3F1. There is
a close correlation in expression of X-linked genes between
these two very different lines (Figure 4C). Further, co-
hybridisation of 3F1 and male (CCE/R) cDNAs from the same
stages of differentiation to the same slides showed a relatively
late decrease in the expression of female X-linked genes
relative to male, with no detectable decrease in female:male
expression ratio (M value) after 2 d of differentiation, and
complete equalisation only after 15 d (Figure 4D).
By studying the change in M value with differentiation
time for individual genes, it became clear that some genes
consistently showed a relatively early loss of activity in female
cells, while others inactivated later, or not at all. Differences
in silencing times were conﬁrmed by real-time quantitative
(RTQ)-PCR assays, in which expression levels in differ-
entiating embryoid bodies were expressed relative to levels
at day 0 (examples are presented in Figure S4). As a ﬁrst test
of whether genes that inactivated relatively early in one ES
cell line also inactivated early in others, we co-hybridised
cDNA from undifferentiated cells and cells differentiated for
7 d to the same slide and calculated the day 7:day 0
expression ratio as an M value. Genes showing reduced
expression in PGK12.1 cells after 7 d of differentiation
Figure 2. Expression of X-Linked Genes in Male and Female ICM
(A) Gel showing presence or absence of PCR products derived from the Sry gene in trophectodermal material from single blastocysts used for ICM cDNA
preparation. Lane 1, 123 bp size markers; lane 2, male embryo; lane 3, female embryo; lane 4 male ES cell line CCE/R.
(B) Correlation in expression levels of X-linked genes between female (y-axis) and male (x-axis) ICMs. The value for each gene is expressed relative to the
expression of autosomal genes (X:A ratio, log2 scale). Pearson product moment correlation coefficient (r value) and FDR-corrected probability of chance
correlation (p) are shown.
(C) Box plot showing expression of X-linked genes (X:A ratio) in male and female ICMs. The box encompasses the 25th–75th percentile, and the upper
and lower lines represent the 10th–90th percentile. Outlying values are shown as individual dots. Female values are from two biological replicates and
male values from two technical replicates.
(D) Expression of the Y-encoded, male-specific antigen Eif2s3y and Xist RNA, relative to autosomal genes (log2 ratio), in ICMs from female and male
embryos.
doi:10.1371/journal.pbio.0050326.g002
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Dosage Compensation in Embryonic Stem Cellstended also to show reduced expression in 3F1 cells, with a
good overall correlation between the two cell lines in the
change in expression of X-linked genes after 7 d of
differentiation (p , 0.001, Figure S5).
We subjected the PGK12.1 M value dataset (Figure 4A) to
cluster analysis using the TIGR programme [21]. The
programme grouped expression data from 252 X-linked
clones into selected numbers of clusters, based on the manner
in which expression (M value) changed during differentiation.
Figure 5A shows the results of an analysis in which the data
were resolved into four clusters, each shown as a graph
plotting the median value at each stage of differentiation
tested. Figure 5B shows the corresponding heat maps.
Clusters 1, 2, and 3 showed similar patterns of change,
starting at an M value of 0.6–0.8 at day 0 (corresponding to a
linear F:M ratio of 1.54–1.75) falling to around 0 by day 21,
but differing in the stage at which M values ﬁrst fell
signiﬁcantly, i.e., day 4–7 for cluster 1 (46 genes), day 7–12
for cluster 2 (74 genes), and day 12–21 for cluster 3 (64 genes).
In contrast, the 21 genes in the fourth cluster behaved
differently, with M values close to 0 in undifferentiated cells
(median ¼  0.14) and generally increasing on differentiation
(Figure 5A). We note that irrespective of how many clusters
the programme was asked to resolve, there was always one
that showed essentially the same pattern as that of cluster 4
and that stood out from the rest. The genes in cluster 4 are
listed in Table S1. They include Xist, a gene known to show
increased expression in female cells as they differentiate [22]
(Figure S1C). Ontology analysis using Fatigoþ [23] showed
that none of these four gene clusters was signiﬁcantly
enriched in genes associated with speciﬁc functional catego-
ries or cell lineages (unpublished results).
Some X-Linked Genes Show Mono-Allelic Expression in
Undifferentiated Female ES Cells
One explanation (among several) for the ﬁnding that some
genes are equally expressed in XX female and XY male ES
cells is that they are expressed from only one allele in female
cells. This could result from the failure to reactivate the
paternal allele which, for most X-linked genes, is selectively
silenced in the preblastocyst embryo but reactivated in the
inner cell mass during blastocyst maturation [17,24]. Alter-
Figure 3. Dynamics of Change in X-Linked Gene and Autosomal Gene Expression during ES Cell Differentiation
(A) Expression of X-linked genes (X:A ratio, log2 scale) in female (red) and male (blue) ES cells at different stages of differentiation from day 0
(undifferentiated) to day 21. Each data point (6 SE) is the averaged median value from 5 (day 21), 4 (day 0), 3 (day 12), or 2 (days 2, 4, 7, 15) biological
replicates. (See Text S1 for details).
(B) RNA FISH showing distribution of Xist RNA (green) in undifferentiated (day 0, upper panel) and differentiating (day 5, lower panel) female ES cells,
counterstained with DAPI (red). The prominent, widely spread Xist signal was detected in ;60% of day 5 cells.
(C) Expression of genes on Chromosome 2 (n:A ratio, log2 scale) in female (red) and male (blue) ES cells at different stages of differentiation. Replicates
as in (A).
doi:10.1371/journal.pbio.0050326.g003
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Dosage Compensation in Embryonic Stem Cellsnatively, it could reﬂect initiation of (random) X inactivation
before the onset of ES cell differentiation. To explore these
possibilities, we assayed the expression of paternal and
maternal alleles using the hybrid ES cell line 3F1, derived
from a m.mus domesticus (129/sv) 3 m.mus castaneous hybrid
backcrossed to 129 [25]. The 129 X chromosome is maternally
derived, whereas the castaneous X chromosome is paternal
[26]. In 3F1 cells, the 129 X chromosome carries a loss-of-
function Tsix mutation, such that when 3F1 cells differentiate,
Xist is always up-regulated on the 129 X chromosome, which
is therefore always inactivated [25].
We identiﬁed single nucleotide polymorphisms (SNPs) in
three cluster 4 genes (Jarid1c, Gm784,a n dAcsl4)t h a t
distinguished the 129 and castaneous alleles and that could
be selectively restriction digested so as to generate cDNAs
that are distinguishable electrophoretically . Remarkably, for
all three genes, expression in undifferentiated 3F1 cells was
exclusively from the castaneous allele (Figure 6A). We were able
to test three other genes that showed a female:male
expression ratio of close to 1 at day 0, but which the TIGR
programme had not placed in cluster 4. One of these, Phka2,
showed expression exclusively from the castaneous allele in
undifferentiated 3F1 cells; a second, Ogt, showed expression
that was strongly skewed towards the castaneous allele; whereas
Figure 4. A Fall in X-Linked Gene Expression in Female ES Cells Is Detected Late in Differentiation
(A) M values (female:male expression ratio, log2 scale, 6SE) for X-linked genes in PGK12.1 female ES cells at different times of differentiation (days 0–21).
The fall in M value is attributable to the progressive inactivation of genes on one of the two female Xs. Biological replicates for PGK12.1 cells are as listed
in Figure 3A.
(B) Distribution of M values in PGK12.1 ES cells at different days of differentiation (day 0, day 2, etc., as indicated) and adult lymphocytes. All
distributions are normal with a progressively decreasing median.
(C) Correlation in expression levels of X-linked genes between 3F1 (y-axis) and PGK12.1 (x-axis) ES cell lines. The value for each X-linked gene is
expressed relative to the expression of autosomal genes (X:A ratio, log2 scale). Pearson product moment correlation coefficient (r value) and FDR-
corrected probability of chance correlation (p) are shown.
(D) M values (female:male expression ratio, log2 scale, 6SE) for X-linked genes in 3F1 female ES cells at different times of differentiation (days 0, 2, 12,
and 15).
doi:10.1371/journal.pbio.0050326.g004
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Dosage Compensation in Embryonic Stem Cellsthe third, Brodl, showed bi-allelic expression (Figure 6B). Two
genes whose female:male expression ratios in undifferenti-
ated cells showed the expected female bias by microarray
analysis (Pctk1 and Zfp185) showed clear biallelic expression,
as did a third gene (Pgr15l), for which a suitable SNP was
available but which was not present on the NIA15K array
(Figure 6B, supplementary Figure S6). The conclusion from
these results is that a subpopulation of X-linked genes in
female ES cells is mono-allelically expressed before differ-
entiation and that in 3F1 cells, where inactivation is 100%
Figure 5. Genes Are Silenced at Widely Differing Times during Differentiation of Female ES Cells
(A) X-linked genes on the array were separated into four clusters on the basis of their patterns of change in female:male expression ratio (M values)
during ES cell differentiation. Median values (6 SE) for each cluster at each time point are shown. Changes in M value are attributable to the progressive
inactivation of genes on one of the two female Xs.
(B) Heat maps for each gene, with female:male expression ratio colour-coded from green (lowest) to red (highest) as shown on the coloured bar (lower
right). Xist (cluster 4, arrowed) shows relatively strong expression in female cells from early in differentiation.
doi:10.1371/journal.pbio.0050326.g005
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Dosage Compensation in Embryonic Stem Cellsskewed towards the maternal X, it is always the paternal
(castaneous) X that is expressed. Thus, mono-allelic expression
is not due to failure to reactivate the paternal allele from its
preblastocyst silent state, but instead is due to the onset of
‘‘random’’ X inactivation before differentiation.
For all genes tested that showed biallelic expression in
undifferentiated cells (Brodl, Zfp185, Ogt, Pctk1, and Pgr151),
allele-speciﬁc analysis conﬁrmed the microarray data, show-
ing that inactivation of X-linked genes occurs over a wide
range of differentiation times and that individual genes have
characteristic times of inactivation (Figure 6B and Figure S6).
Proximity to the X inactivation centre (Xic) Correlates with
Mono-Allelic Expression in Undifferentiated Female ES
Cells
In searching for possible reasons for the gene-to-gene
differences in inactivation rate, we asked whether position on
the X chromosome, and speciﬁcally proximity to Xist and the
Xic, was of any relevance. To do this, we tabulated the
distribution of genes in each cluster across seven X
chromosome regions of similar gene content (Table S2).
Genes in clusters 1–3 are distributed across the X chromo-
some with no clear enrichment or depletion in any single
region, nor any clear differences between clusters. In
contrast, cluster 4 showed a signiﬁcant enrichment in the
region (85–108Mb) that contains the Xic (8 of 21 genes, p ¼
0.038, Fisher’s exact test). Six of these eight genes are within 6
Mb (94.8;100.5 Mb) of the Xic (Tables S1 and S2).
The tendency of genes silenced before ES cell differ-
entiation to be located adjacent to the Xic suggests that Xist
RNA plays a role in their silencing, even before its increased
expression early in differentiation. To test this, we took
advantage of the ﬁnding that Xist transcript levels in
undifferentiated 3F1 cells (carrying a mutation of the Tsix
gene) are about 3-fold higher than in the 16.6 hybrid line,
from which 3F1 was derived [25] and which has a functional
Tsix gene [22]. In 16.6 cells, inactivation is 80% skewed
towards the 129 X chromosome as a result of differences in
strength of the Xce alleles in the parental strains [27,28]. In
undifferentiated 16.6 cells, two of the four genes that are
mono-allelically expressed in 3F1 cells (Gm784, Acsl4) were
also expressed exclusively from the castaneous allele. However,
the two that were most distant from the Xic (Phka2, Jarid1c)
were bi-allelically expressed (examples shown in Figure 6C),
consistent with the possibility that silencing reﬂects local
spreading of Xist RNA.
If silencing of X-linked genes reﬂects the progressive
spreading of Xist RNA through the X chromosome territory,
then one would predict that genes that are close together on
the chromosome should be silenced at similar times. To test
this, we prepared a list of X-linked gene pairs separated by
progressively increasing distances, and we asked whether
members of each pair were found in the same cluster (i.e., any
one of clusters 1–4, Figure 4) more often than expected by
chance. For this analysis, the four clusters are taken as broad
indicators of inactivation timing. We ﬁnd that gene pairs
separated by up to 40 kb (Table S3) are in the same cluster
signiﬁcantly more often than predicted by chance (p , 0.05,
statistical procedures used are outlined in Text S1 and Figure
S7). The ﬁve closest gene pairs, from 0 to 2.8 kb apart, were
always present in the same cluster (p , 0.05, Table S3).
Discussion
The results presented here use microarray expression
analysis to show that dosage compensation in mouse ES cells
involves up-regulation of X-linked genes in both males and
females, together with the progressive, differentiation-de-
pendent silencing of genes on one of the two female X
chromosomes. We ﬁnd that up-regulation is present prior to
Figure 6. Allele-Specific Analysis of X-Linked Gene Expression during
Differentiation of Hybrid (129 3 castaneous) Female ES Cells
(A) Electrophoretic separation of cDNA restriction fragments from the
three cluster 4 genes Acsl4, Jarid1c, and GM784 reveals allele-specific
expression. PCR fragments that are specific for each gene were prepared
from cDNAs from undifferentiated (day 0) or differentiated (day 12) 3F1
hybrid ES cells. Fragments were uncut (U) or cut (C) with restriction
enzymes, so as to reveal SNPs that distinguish m.m.domesticus (129, black
arrows) and m.m.castaneous (white arrows) alleles. Small double arrows
show where bands of the same size are generated from 129 and
castaneous. For all three genes, the expected 129 product is missing from
both undifferentiated (day 0) and differentiated (day 12) cells, showing
that expression is exclusively from the castaneous allele. cDNA from the
male CCE/R ES cell line provided the 129 control. Details of primers,
restriction enzymes, and expected fragment sizes are given in Table S5.
(B) Electrophoretic separation of cDNA restriction fragments from four X-
linked genes Ogt, Brodl, Pctk1, and Pgr15l to reveal allele-specific
expression in 3F1 hybrid female ES cells at different days of differ-
entiation (days 0–15 as indicated); labelling as for (A).
(C) In undifferentiated 16.6 hybrid female ES cells, cluster 4 gene Acsl4
(upper gel) shows monoallelic expression (castaneous allele only) while
Jarid1c (lower gel) is expressed from both alleles; labelling as for (A).
doi:10.1371/journal.pbio.0050326.g006
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likely female) ICMs. Up-regulation of X-linked gene expres-
sion in male and female cells is consistent with the overall
;1:1 expression ratio of X-linked and autosomal genes
calculated from analysis of publicly available microarray
expression data for a wide range of mouse and human cell
types [11].
Progressive Silencing of X-Linked Genes in Differentiating
Female ES Cells
Increasing the level of Xist RNA transcripts early in
differentiation of female ES cells, is a key event in silencing,
in cis, of X-linked genes [6,22]. The more extensive Xist signal
detected by RNA-FISH, following up-regulation, has been
thought to represent ‘‘coating’’ of the X chromosome, an
event that triggers gene silencing. However, the data
presented show that global silencing of X-linked genes in
differentiating ES cells is not contiguous with the onset of Xist
up-regulation, but is put in place progressively over several
weeks of differentiation. Indeed, we ﬁnd no general relation-
ship between transcriptional silencing and any one of the
chromosome-wide changes that ﬁrst become apparent on Xi
at speciﬁc stages of ES cell differentiation, including Xist
coating and H3 lysine 9 methylation (days 1–2), histone
deacetylation (days 5–7), and incorporation of the histone
variant macroH2A (days 8–12) [20,29–31].
The slow, progressive fall in X-linked transcripts is not
easily attributable to experimental or technical factors. Falls
in transcript levels inevitably lag behind transcriptional
silencing and will show a spread of values that reﬂects how
promptly individual cells begin to differentiate, but such
effects cannot account for the consistent variation from one
gene to another in the stage at which transcript levels fall.
Nor can differences in RNA turnover or stability account for
the gene-to-gene variation in silencing time. An unstable
transcript will vanish as soon as transcription stops, while a
completely stable transcript will be diluted 2-fold at each cell
division (i.e., every 16–18 h). Even these extreme stability
differences cannot explain variations in inactivation time
spread over 3 wk of differentiation. Strain-related differences
in global gene expression patterns in different ES cell lines
have recently been carefully documented [15], but we ﬁnd no
evidence that differences between ES cell lines, or the mouse
strains from which they were derived, are fundamentally
inﬂuencing our results. Levels of expression of the X-linked
genes on the NIA15K array were very closely correlated
between CCE/R (129/sv), PGK12.1 (PGK 3 129/OLA), and 3F1
(129 3 m.mus castaneous) ES cells, whereas both overall up-
regulation of X-linked gene expression prior to differ-
entiation and the slow decrease in X-linked gene expression
during differentiation were similar in PGK12.1 and 3F1 cells.
Our observation that some genes (e.g., Jarid1c and Acsl4) are
silenced on the chosen X in undifferentiated ES cells shows
that up-regulation of Xist expression is not essential for
silencing. However, the tendency of these early-silencing
genes to lie close to the Xist locus suggests that Xist RNA may
still be involved, possibly through local spreading, the extent
of which is limited by the low level of Xist expression in
undifferentiated cells [22]. This possibility is consistent with
the ﬁnding that whereas four genes were shown by allele-
speciﬁc analysis, to be mono-allelically expressed in undiffer-
entiated 3F1 cells, only two of these show mono-allelic
expression in 16.6 cells, in which Xist transcript levels are 3-
fold lower [22]. The two genes that escape silencing in 16.6
cells (Phka2 and Jarid1c) lie furthest from Xist, a ﬁnding
generally consistent with a local spreading model. These
results also raise the possibility that Jarid1c silencing is
particularly sensitive to Xist expression levels, which might
help explain reports that this gene (previously known as Smcx)
escapes inactivation to varying degrees depending on stage of
differentiation and cell or tissue type [32–34].
Recent data suggest that up-regulation of Xist RNA early in
ES cell differentiation leads to the formation of a distinct Xist
domain within the X chromosome territory, into which genes
are placed as they are silenced [20,35]. The results presented
here are consistent with an Xist domain, but we suggest that
the domain expands through the X chromosome territory as
differentiation proceeds, and that genes are silenced as they
come into contact with the spreading Xist RNA. The
progressive increase in Xist transcript levels during differ-
entiation of female, but not male, ES cells (Figure S1C) is
consistent with an expanding Xist domain. The stage at which
any gene is silenced will therefore depend on its position
within the X chromosome territory relative to the Xist locus.
These positions will depend on how the X chromosome is
folded within its territory, and for all genes except those most
proximal to Xist, the folding need bear little relationship to
the gene’s (linear) position on the chromosome, which we ﬁnd
to be the case (Table S2). We do ﬁnd, as predicted by the
spreading model, that genes that lie close together on the
chromosome (within about 40 kb) tend to be silenced at about
the same time, as measured by cluster analysis (Table S3).
None of this evidence is inconsistent with the possibility that
some genes at least may be actively drawn into the Xist
domain [20]; it is possible that Xist spreading and gene
repositioning occur in parallel.
In the model we propose, the pattern of gene silencing
through differentiation is critically dependent on the con-
ﬁguration of the X chromosome territory, speciﬁcally the
positioning of the Xist locus and of other loci relative to it.
Differential reconﬁguration of X chromosome territories in
female cells prior to the onset of X inactivation, or even
changes in their intranuclear location, may be a crucial initial
step in the X inactivation process [22,36]. The fact that XY
male ES cells express low levels of Xist RNA prior to
differentiation, but do not inactivate genes proximal to Xist
(e.g., Gm784, Acsl4, Figure 6), indicates that Xist RNA is not the
sole determinant of inactivation. Perhaps conﬁguration of
the X chromosome territory or chromatin conformation in
undifferentiated male ES cells is such as to preclude contact
between Xist RNA and critical X-linked loci. Our previous
observation that X-linked genes in female ES cells carry levels
of histone modiﬁcations associated with transcriptional
activity that are higher than those in males [37] raises the
intriguing possibility that chromatin modiﬁcations might
help determine susceptibility to Xist silencing. In this respect,
it is interesting that the dosage compensation complex in D.
melanogaster, which includes roX RNAs, preferentially targets
transcriptionally active genes, possibly through their distinc-
tive histone modiﬁcations [3,4,38].
Evolutionary Considerations
Dosage compensation is a rapidly evolving process, and the
mechanisms by which it is accomplished vary from one
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evolution is driven predominantly by a need to equalise
overall X-linked and autosomal expression levels, or whether
transcript levels of key individual genes exert the major
selection pressure. Recent studies on expression of Z-linked
genes in birds, in which females are heterogametic (ZW) and
males homogametic (ZZ), throw some interesting light on this
[39]. For a representative group of genes in various tissues in
two species (zebra ﬁnch and chicken), the expression of Z-
linked genes was consistently and signiﬁcantly higher in ZZ
males—where the Z:autosome expression ratio was around
1—than in ZW females—where the Z:autosome ratio ranged
from 0.7 to 0.9 depending on the tissue. These ﬁndings
indicate that dosage compensation is incomplete in birds,
and that higher eukaryotes can tolerate signiﬁcant overall
differences in gene expression between the sexes and
between X-linked and autosomal genes.
It now seems that the three model organisms commonly
used to study dosage compensation: fruit ﬂy (D. melanogaster),
mouse (Mus musculus), and the nematode worm Caenorhabditis
elegans have all adopted up-regulation of X-linked gene
expression in XY (or XO) males as a means of balancing
X:autosome expression levels [1,38]. In mouse and C. elegans
[40,41] there is also an overall suppression of X-linked
transcription in XX females/ hermaphrodites. The extra
complexity of the mammalian, and worm, mechanisms is
likely to reﬂect their evolutionary histories. It is generally
accepted that the gene-poor Y chromosome is the evolu-
tionary result of progressive degeneration of one of two
originally homologous chromosomes, one of which (the
proto-Y) carried a sex-determining allele [42,43]. Restricted
crossing-over at and around the sex-determining locus, which
is necessary to prevent the formation of intersex states, allows
the progressive spread of mutations and the loss of functional
genes along the proto-Y by reducing the selection pressure to
which they are subjected [8]. For many mutated genes,
selection pressure will favour up-regulation of the remaining
functional allele to restore the original transcript levels. The
magnitude of this selection pressure will depend on the
sensitivity of the gene product’s function to transcript level. If
in mammals (and C. elegans), unlike Drosophila, the newly
evolving up-regulation mechanism were expressed from the
beginning in both males and females, then a female-speciﬁc
silencing mechanism would need to evolve in parallel to
suppress damaging overexpression [38,42]. The fact that the
up-regulation of X-linked genes in Drosophila is male-speciﬁc,
whereas that in the mouse is not, suggests that the
mechanisms by which up-regulation is achieved may be
fundamentally different in the two organisms, despite the
presence in mammals of homologues of several of the
Drosophila dosage-compensation complex components
[44,45]. Unravelling the up-regulation mechanism in mam-
mals and deﬁning how it interacts, if at all, with Xist-mediated
silencing to optimise expression of X-linked genes are now
questions of particular interest.
Materials and Methods
Cells and cDNA preparation. The mouse ES cell lines PGK12.1 (129
3 PGK hybrid) [46], CCE/R (129/sv) [47], and 3F1 (129/sv 3 castaneous
hybrid) [25] were cultured as previously described [37]. Differ-
entiation was induced by replating on nonadherent plastic dishes
in the absence of leukaemia inhibitory factor (LIF). Adult control
cells were thymic lymphocytes from 4-wk-old Balb/c mice. ICM cells
were prepared from cultured Balb/c mouse embryos at the early
blastocyst stage by the immunosurgery procedure of Solter and
Knowles [48], as previously described [49]. Embryos were sexed by
testing (by PCR) the trophectodermal material remaining after
immunosurgery for presence of DNA encoding the male-speciﬁc, Y-
linked antigen Sry.
Total RNA was extracted from ES cells using the RNeasy mini kit
(Qiagen). For ICM, RNA was extracted with the RNAqueous-Micro kit
and ampliﬁed with the MessageAmp II aRNA ampliﬁcation kit (both
from Ambion). cDNA was prepared with RT-Superscript-III (Invi-
trogen), puriﬁed with the Qiagen PCR puriﬁcation kit, and labelled
with Cy3 or Cy5 (Amersham) using Invitrogen Bioprime labelling kits
(see Text S1 for details).
cDNA microarrays. The NIA 15K mouse cDNA library [14,50] was
purchased through the UK Medical Research Council and printed in
duplicate onto glass slides by the Genomics and Proteomics
Laboratory, University of Birmingham (http://www.genomics.bham.
ac.uk) using an Advalytix Automated Hybrydization Station. The
library contains 15,247 cDNA clones with an average insert size of 1.5
kb. The ES cell data presented here are derived from 252 X-linked
clones (corresponding to 180 named genes) and 6,945 autosomal
clones (corresponding to 5,085 named genes) that consistently gave
above-background signals with ES cell cDNAs. cDNAs from female
and male ES cells at the same stage of differentiation were labelled
with Cy3 and Cy5, and equal amounts (80;120 pmol) were co-
hybridised to arrays overnight at 42 8C. After labelling, slides were
washed and then scanned using a GenePix 4000A scanner. PMT
settings were set so as to balance overall signal in the Cy3 and Cy5
channels. Scans were automatically aligned using GenePix (version
6.0) software and then ‘‘cherry-picked’’ manually to eliminate
abnormal spots. Microarray data was extracted by Genepix (version
6.0) and normalised by Gepas software. Clustering analysis used the
TIGR MultiExperiment Viewer, TMEV [21] (http://www.tigr.org/tdb/
tgi). Detailed analytical procedures can be found in Text S1.
Real-time PCR and SNP analysis. Expression patterns of four genes
(Maoa1, Prps1, Ssr4, and Smc1l1) were quantiﬁed by real-time PCR
using SYBR Green PCR master mix (ABI) and an ABI 7900 Detection
System. The primer sequences are listed in Table S4. Allele-speciﬁc
quantiﬁcation of Zfp185 was by radioactive PCR with two forward
primers (Table S4), speciﬁcally recognising 129 and castaneous alleles.
ActB was used as a control. The PCR reaction comprised 5 ll2 3
buffer, 1 ll cDNA, and 2.5 pmol each of primers in a total volume of
10 ll.
SNPs distinguishing m.m.domesticus (129) and m.m.castaneous X-linked
genes were identiﬁed using Ensemble SNPView. Allele-speciﬁc
expression was analysed by restriction enzyme digestion following
ampliﬁcation of cDNA from undifferentiated (day 0) 3F1 cells by
PCR. Primers, enzymes, and expected products are listed in Table S5
and detailed procedures are given in Text S1.
RNA FISH. RNA FISH was carried out as described by Okamoto et
al. [17]. Brieﬂy, cells were cytospun to glass slides and ﬁxed in 3.5%
paraformaldehyde in PBS for 30 min at room temperature and
permeabilised with 0.5% Triton X100 in PBS þ 2 mM vanadyl
ribonucleoside complex (Biolab) for 10 min on ice. Cells were then
dehydrated, hybridised, and counterstained with DAPI. The 6-kb
GPT16 Xist probe [51] was labelled with Spectrum Green-dUTP
(Vysis) by nick translation, according to the manufacturer’s protocol.
Supporting Information
Figure S1. Expression of Xlr5 and Xlr3b during ES Cell Differentiation
(A) Microarray-derived expression of the Xlr5 and Xlr3b genes in male
(CCE/R) and female (PGK12.1) ES cells, as indicated, at different days
of differentiation.
(B) Microarray-derived expression of the Nanog, Pou5f1, and Zfp42
genes in female (PGK12.1) ES cells at different days of differentiation.
(C) Microarray-derived expression of the Xist gene in female
(PGK12.1) ES cells at different days of differentiation. Expression is
relative to autosomal genes (log2X:A ratio).
Found at doi:10.1371/journal.pbio.0050326.sg001 (38 KB PPT).
Figure S2. Distribution of Expression Levels of X-Linked and
Autosomal Genes in Male and Female ES Cells
X-linked gene expression in undifferentiated and differentiated ES
cells shows a distribution skewed towards higher expression levels. In
undifferentiated cells only, the median expression is higher in
females than in males. Autosomal genes show a similar distribution
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change with differentiation; the distributions for genes on Chromo-
somes 2 and 10 are shown as examples.
Found at doi:10.1371/journal.pbio.0050326.sg002 (45 KB PPT).
Figure S3. Expression of Genes on Individual Autosomes by Micro-
array Analysis
Expression levels of genes on individual Chromosomes 1–19, relative
to expression from all autosomes (n:A ratio), in female (red) and male
(blue) ES cells through differentiation are shown. None of the
autosomes show any consistent difference between males and females
or any change with differentiation, with the exception of Chromo-
some 11, whose genes are consistently more strongly expressed in
males, and Chromosome 12, whose genes are consistently more
strongly expressed in females. However, these expression differences
are small compared to those shown by X-linked genes.
Found at doi:10.1371/journal.pbio.0050326.sg003 (60 KB PPT).
Figure S4. Fold Change in Expression of Some X-Linked Genes
During Female ES Cell Differentiation
(A) Array-derived expression ratios of Maoa1, Prps1, Ssr4, and Smc1l1
at different days of differentiation in ES cell. Data for each gene was
normalised to day 0.
(B) Real-time PCR validation of array-derived expression ratio. ActB
was used as an endogenous, internal control and the data was
normalised to day 0 values thereafter, as in (A).
Found at doi:10.1371/journal.pbio.0050326.sg004 (34 KB PPT).
Figure S5. Correlation between Genes Inactivated in PGK12.1 and
3F1 ES Cells after 7 d of Differentiation
The graph shows how levels of expression of individual X-linked
genes change after 7 d of differentiation in two female ES cell lines:
PGK12.1 (x-axis) and 3F1 (y-axis). For each cell line, cDNAs from
undifferentiated and differentiated cells were co-hybridised to the
same slide, and the difference in expression was calculated as an M
value (day 7:day 0 ratio, log2 scale). Pearson product moment
correlation coefﬁcients (r value) and probabilities of chance
correlation (p) are shown. These experiments were carried out with
an NIA15K ‘‘half library’’, and the number of data points is less than
shown in other ﬁgures.
Found at doi:10.1371/journal.pbio.0050326.sg005 (34 KB PPT).
Figure S6. Allelic Expression of Zfp185 during Female ES Cell
Differentiation
(A) Two forward primers (Table S4) hybridize selectively to the SNP
that distinguishes the 129 and castaneous alleles of Zfp185 in 3F1
hybrid ES cells.
(B) Allele-speciﬁc analysis shows reduced expression of Zfp185 from
the 129 allele by day 7 of 3F1 differentiation.
Found at doi:10.1371/journal.pbio.0050326.sg006 (63 KB PPT).
Figure S7. Measured Frequency of ‘‘Same-Cluster’’ Gene Pairs in
Groups of Five or More Gene Pairs Separated by Increasing Distances
The blue line shows the measured frequency of gene pairs in which
both genes were in the same cluster as group size increased to
incorporate gene pairs that were increasingly far apart. The 20 closest
gene pairs (up to 40 kb apart) are shown in Table S3. The red line
shows the frequencies representing the 95th percentile for each
group, calculated as described above.
Found at doi:10.1371/journal.pbio.0050326.sg007 (32 KB PPT).
Table S1. Clones and Corresponding Genes in Cluster 4
Chromosome locations are from the online data provided for
the NIA15K array (http://www.nia.nih.gov).
Found at doi:10.1371/journal.pbio.0050326.st001 (37 KB DOC).
Table S2. Gene Distribution along the X Chromosome
(A) Distribution along the X chromosome of clones in clusters 1–4.
(B) Distribution along the X chromosome of genes in clusters 1–4.
(C) Distribution along the X chromosome of genes in clusters 1–4 as a
proportion of genes in each cluster.
Found at doi:10.1371/journal.pbio.0050326.st002 (52 KB DOC).
Table S3. Relationship between the Proximity of Genes within a Gene
Pair and Their Presence within the Same or Different Clusters
For the purposes of statistical analysis, pairs were counted as one if
they were within the same cluster and zero if they were in different
clusters; see also Figure S7.
Found at doi:10.1371/journal.pbio.0050326.st003 (46 KB DOC).
Table S4. Primer Pairs Used for Real Time PCR Validation of
Microarray Data
Found at doi:10.1371/journal.pbio.0050326.st004 (35 KB DOC).
Table S5. Primers and Restriction Enzymes Used for Allele-Speciﬁc
Analysis of Selected X-Linked Genes
Found at doi:10.1371/journal.pbio.0050326.st005 (42 KB DOC).
Text S1. Details of Statistical Procedures Used for Analysis of
Microarray Data and Technical Procedures Used for cDNA Prepa-
ration, PCR, and SNP analysis
Found at doi:10.1371/journal.pbio.0050326.sd001 (46 KB DOC).
Accession Numbers
The National Center for Biotechnology Information (NCBI) unigene
cluster IDs (http://www.ncbi.nlm.nih.gov) for the genes mentioned in
the text are as follows: Acsl4 (Mm.391337), Brodl (Mm.100112), Gm784
(Mm.298000), Jarid1c (Mm.142655), Nanog (Mm.440503), Ogt
(Mm.259191), Pctk1 (Mm.102574), Pgr151 (Mm.336164), Phka2
(Mm.350712), Pou5f1/Oct4 (Mm.17031), Sry (Mm.377114), Tsix
(Mm.435573), Xist (Mm.435573), Xlr3b (Mm.336117), Xlr5
(Mm.435653), Xlr5c (Mm.255790), Xlr5d (Mm.435653), Zfp42/Rex1
(Mm.285848), and Zfp185 (Mm.1161).
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